Breaking News

Biofortuna Expands Immunoassay Services

Invests in production capabilities for immunoassay design, development and manufacture

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Biofortuna is expanding its IVD service portfolio to provide more focus on immunoassay design, development and manufacture. The company has invested in its production capabilities to include plate coating, washing, drying and quality control, as well as a manufacturing suite for immunoassay kits.   This expansion was driven by current customer projects and increasing demand from the market. These enhanced manufacturing capabilities expand existing immunoassay services and offers increased flex...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters